期刊文献+

胆囊癌中基质金属蛋白酶9表达与淋巴结转移及预后的关系 被引量:4

Expression of MMP-9 correlates with lymph node metastasis and prognosis in gallbladder carcinoma.
暂未订购
导出
摘要 目的 研究胆囊癌中基质金属蛋白酶 9(MMP 9)表达的情况 ,探讨MMP 9表达的临床意义。方法 应用免疫组化Envision二步法测定 4 6例胆囊癌 (gallbladdercarcinomaGBC)和 12例慢性结石性胆囊炎、3例胆囊腺瘤中MMP 9表达。结果 MMP 9在胆囊癌组织中阳性表达率为 78 2 6 % ,胆囊癌组织与胆囊良性病变MMP 9表达水平之间有显著性差异 (P <0 0 0 1)。MMP 9表达与胆囊癌分化程度、临床分期、淋巴结转移、术后生存率有关。结论 MMP 9的表达可以作为判断胆囊癌淋巴结转移、评估预后的指标。 Objective To investigate the clinical significance of MMP 9 protein expression in primary gallbladder carcinoma(GBC).Methods The immunohistochemical Envision technique was adopted for detecting the MMP 9 protein expression in 46 cases of GBC, 12 cases of chronic cholecystitis and 3 cases of gallbladder adenoma.Results The positive rate of MMP 9 expression in gallbladder carcinoma was 78.26%, and the difference of MMP 9 expression between GBC and gallbladder benign lesions had statistical significance( P <0 001). The positive expression of MMP 9 is correlated with the pathologic differentiation, clinic staging, lymph node metastasis and postoperation survival rate.Conclusion Detecting MMP 9 expression might be served as an objective indicator for lymph node metastatic potency and prognosis in gallbladder carcinoma.
出处 《陕西肿瘤医学》 CAS 2002年第3期164-165,共2页 ShanXi Oncology Medicine
关键词 淋巴结转移 预后 胆囊癌 基质金属蛋白酶9 免疫组织化学 GBC gallbladder carcinoma matrix metalloproteinase 9 immunohistochemistry
  • 相关文献

参考文献9

  • 1Nevin JE, Moran TJ, Kay S, et al. Carcinoma of the gallbladder:staging, treatment and prognosis[J]. Cancer, 1976,37(1):141-148.
  • 2Davis B, Waxman H, Wasan H, et al. Levels of matrix metalloproteinasein bladder cancer correlate with tumor grade and invasion[J].Cancer Res, 1993,53(22) :5365-5369.
  • 3Aznavorian S, Murphy AN, Stetler WG, et al. Molecular aspects of tumor cell invasion and metastasis[J]. Cancer, 1993,71 (4) : 1368 -1383.
  • 4Liabakk NB, Talbot I, Smith RA, et al. Matrix metalloproteinase 2 (MMP-2) and matrix metalloproteinase 9(MMP-9) type Ⅳ collagenase in colorectal [J]. Cancer Res, 1996,56(1):190-196.
  • 5李泽良,刘同才,孙志熙,王平,孔垂泽,温强.MMP2、MMP9在肾癌中的表达及意义[J].中国医科大学学报,2001,30(4):299-300. 被引量:4
  • 6Nomuro H, Sato H, Seiki M, et al. Expression of membrane- type matrix metalloproteinase in human gastic carcinoma[J]. Cancer Res,1995,55(15) :3263-3266.
  • 7Yamamoto H, Itoh F, A dachi Y, et al. Ralation of enhanced secretion of active matrix metalloproteinase with tumor spread in human hepatocelluler carcinoma[J]. Gastroenterology, 1997, 112(4): 1290-1296.
  • 8蔡阳,吴志全,樊嘉,封光华,贺斌,刘银坤,叶胜龙,汤钊猷.肝癌中基质金属蛋白酶-9表达的临床意义[J].中华肝胆外科杂志,2001,7(1):48-48. 被引量:2
  • 9Fujise N, Nanashima A, Taniguchi Y, et al. Prognotic impact of Cathepsin B and matrix metalloproteinase - 9 in pulmonary adenocarcinomas by immunohistochemical study[J]. Lung Cancer, 2000,27(1) :19-26.

二级参考文献6

  • 1[1]Ray JM,Stetler,Stevenson WG. The role of matrix metalloproteinasesand their inhibitors in tumor invasion,metastasis and angiogenesis.Eur J Respir Dis,1994,7:2062-2072
  • 2[2]Kugler A, Hemmerlein B, Thelen P, et al. Expression of metalloproteinase 2 and 9 and their inhibitors in renal cell carcinoma. J Urol, 1998,160:1914-1918
  • 3[3]Miyajima Y,Nakano R,Morimatsu M. Analysis of expression of matrix metalloproteinases-2 and -9 in hypopharyngeal squamous cell carcinomal by in situ hybridization. Ann Otol Rhinol Laryngol, 1995, 104: 678
  • 4[4]Gohji K, Fujimoto N. Koiyama T, et al Evaluation of Serum levels of recurrence in patients with urothelial carcinoma, Cancer, 1996,78: 2379-2387
  • 5[5]Kugler A, Matrix metalloproteinases and their inhibitors. Anticancer Res, 1999,19: 1589-1595
  • 6蔡阳.基质金属蛋白酶-9在临床上的应用[J].国外医学(外科学分册),1998,25(6):329-332. 被引量:12

共引文献4

同被引文献44

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部